Signaling Pathway
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
| Discription | Umeclidinium bromide(GSK573719A) is a muscarinic receptor antagonist which is useful in treatment of chronic obstructive pulmonary disease (COPD). |
|---|
| Catalog Num | A15268 |
|---|---|
| Formula | C29H34BrNO2 |
| Molecular Weight | 508.49 |
| CAS Number | 869113-09-7 |
| SMILES | C1C[N+]2(CCC1(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)CCOCC5=CC=CC=C5.[Br-] |
| Synonyms | GSK573719A, GSK-573719A, GSK 573719A |
| Storage | Store lyophilized at -20ºC, keep desiccated. |
| In vitro | DMSO | 94 mg/mL (184.86 mM) | |
| Water | Insoluble | ||
| Ethanol | 11 mg/mL (21.62 mM) | ||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 19.67 mL | 98.33 mL | 196.66 mL |
| 0.5 mM | 3.93 mL | 19.67 mL | 39.33 mL |
| 1 mM | 1.97 mL | 9.83 mL | 19.67 mL |
| 5 mM | 0.39 mL | 1.97 mL | 3.93 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
